Century Therapeutics Inc

IPSCNASDAQ · USD
1.86USD0.00 (-6.07%)
1510

Century Therapeutics Inc (IPSC) Straddle

IPSC straddle scan found 6 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 77.4%.

Read more

Trading a IPSC straddle lets you take a pure volatility position on Century Therapeutics Inc without committing to a direction. Century Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate IPSC straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on IPSC profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Century Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the IPSC straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma.

Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the IPSC straddle is the cleanest expression of that view. Our scanner prices every IPSC straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a IPSC straddle into a catalyst or short a IPSC straddle to harvest decay, the options straddle setups that matter are all in one place.

Mar 19, 20272.00$1.0519048%77.4%$3.05$0.950
Apr 16, 20272.50$1.7821848%70.0%$4.28$0.73337
Apr 16, 20272.00$1.4021848%68.2%$3.40$0.600
Jan 15, 20272.00$1.2512748%61.4%$3.25$0.7532
Jan 15, 20271.00$1.5812748%$2.58-$0.586
Mar 19, 20275.00$5.0319048%$10.03-$0.030

As of September 16, 2026

Find the right straddle before volatility moves

Track IPSC straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial